Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.

Tiigimäe-Saar J, Leibur E, Kolk A, Talvik I, Tamme T.

Int J Oral Maxillofac Surg. 2012 Dec;41(12):1540-5. doi: 10.1016/j.ijom.2012.09.015. Epub 2012 Oct 12.

PMID:
23068112
2.

Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.

Banerjee KJ, Glasson C, O'Flaherty SJ.

Dev Med Child Neurol. 2006 Nov;48(11):883-7.

3.

Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.

Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ.

Eur J Pediatr. 2001 Aug;160(8):509-12.

PMID:
11548191
4.

Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.

Wilken B, Aslami B, Backes H.

Neuropediatrics. 2008 Aug;39(4):200-4. doi: 10.1055/s-0028-1112115. Epub 2009 Jan 22.

PMID:
19165707
5.

Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.

Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.

Pediatrics. 2004 Sep;114(3):620-7.

PMID:
15342830
6.

Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.

Alrefai AH, Aburahma SK, Khader YS.

Clin Neurol Neurosurg. 2009 Jan;111(1):79-82. doi: 10.1016/j.clineuro.2008.09.001. Epub 2008 Nov 1.

PMID:
18977585
7.

Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.

Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.

Int J Pediatr Otorhinolaryngol. 2016 Sep;88:142-5. doi: 10.1016/j.ijporl.2016.06.031. Epub 2016 Jun 11.

PMID:
27497402
8.

Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.

Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS.

J Craniofac Surg. 2013 Jan;24(1):28-33. doi: 10.1097/SCS.0b013e31827102a0.

PMID:
23348253
9.

Botulinum toxin A as a treatment for excessive drooling in children.

Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, Camfield CS, Camfield PR.

Pediatr Neurol. 2002 Jul;27(1):18-22.

PMID:
12160968
10.

Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.

Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.

Am J Phys Med Rehabil. 2017 Feb;96(2):68-76. doi: 10.1097/PHM.0000000000000525.

PMID:
28099276
11.

Thickened saliva after effective management of drooling with botulinum toxin A.

Erasmus CE, Van Hulst K, Van Den Hoogen FJ, Van Limbeek J, Roeleveld N, Veerman EC, Rotteveel JJ, Jongerius PH.

Dev Med Child Neurol. 2010 Jun;52(6):e114-8. doi: 10.1111/j.1469-8749.2009.03601.x. Epub 2010 Feb 12. Erratum in: Dev Med Child Neurol. 2010 May;52(5):497.

12.

Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.

Hay N, Penn C.

Int J Lang Commun Disord. 2011 Sep-Oct;46(5):550-63. doi: 10.1111/j.1460-6984.2011.00010.x. Epub 2011 Mar 7.

PMID:
21899672
13.

Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.

Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.

Dev Med Child Neurol. 2008 Feb;50(2):123-8. doi: 10.1111/j.1469-8749.2007.02010.x.

14.

Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?

Nordgarden H, Østerhus I, Møystad A, Asten P, Johnsen UL, Storhaug K, Loven JØ.

J Child Neurol. 2012 Apr;27(4):458-64. doi: 10.1177/0883073811419365. Epub 2011 Sep 21.

PMID:
21940695
15.

Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.

Savarese R, Diamond M, Elovic E, Millis SR.

Am J Phys Med Rehabil. 2004 Apr;83(4):304-11; quiz 312-4, 336.

PMID:
15024333
16.

Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.

Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC.

J Child Neurol. 2011 Jul;26(7):838-43. doi: 10.1177/0883073810395391. Epub 2011 May 6.

PMID:
21551374
17.
18.

Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.

Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.

Dev Med Child Neurol. 2011 Jun;53(6):559-64. doi: 10.1111/j.1469-8749.2011.03952.x. Epub 2011 Mar 17.

19.

Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.

Formeister EJ, Dahl JP, Rose AS.

Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1387-92. doi: 10.1016/j.ijporl.2014.06.005. Epub 2014 Jun 16.

PMID:
24974144
20.

Does motor performance matter in botulinum toxin efficacy for drooling?

Erasmus CE, Scheffer AR, van Hulst K, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.

Pediatr Neurol. 2011 Aug;45(2):95-9. doi: 10.1016/j.pediatrneurol.2011.02.011.

Supplemental Content

Support Center